Genmab — Juni 2018
-
But what can they possible say in general, they have nothing to talk about? TV and AXL are under way. Its not a coffee-club its business, the less you hear the more the work and the more the work the better change for succes so..........schhhhhhh let them work:-)
-
JNJ will of course not use money of something not working, its like i said some weeks ago very common to try again in maybe 5 or 10 years if they dont have another solution. Its only a little trail an not important general so why talk........the money will speak!
-
-
unfortunately a lot of investors will not know the difference between solids, MM and all that ; they see a failure, they already had a 25% drop, and they flee. On top of that, they see in the newspaper that CART is going to cure cancer, so why would anyone need Dara?
Markets are far from perfect... -
Sloan Kettering Institute identifies new way to combat a serious CAR-T cell therapy side effect!! Det bliver spændende at følge! https://www.mskcc.org/blog/study-identifies-new-way-combat-serious-car-cell-therapy-side-effect?sf191604095=1#utm_source=Twitter&utm_medium=Organic&utm_campaign=062218Cart&utm_content=Research
-
Denne presentation er vist ikke så gammel ? http://ir.genmab.com/static-files/883e0329-61cc-418c-8703-cf8cc8e010f1
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind